Southampton Experimental Cancer Medicine Centre (Southampton ECMC)

United Kingdom (UK)

1 October 2019 - 30 September 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Southampton Experimental Cancer Medicine Centre (Southampton ECMC) published between 1 October 2019 - 30 September 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Southampton Experimental Cancer Medicine Centre (Southampton ECMC) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
2 0.07

Outputs by subject (Share)

Subject Count Share
Life Sciences 2 0.07

1 October 2019 - 30 September 2020

International vs. domestic collaboration by Share

  • 37.61% Domestic
  • 62.39% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (6 total)

  • Southampton Experimental Cancer Medicine Centre (Southampton ECMC), United Kingdom (UK)
  • Domestic institution
  1. Babraham Institute, United Kingdom (UK) (0.47)
    0.03
    0.44
  2. University of Cambridge, United Kingdom (UK) (0.31)
    0.03
    0.28
  3. Queen Mary University of London (QMUL), United Kingdom (UK) (0.20)
    0.04
    0.16
  4. GlaxoSmithKline plc. (GSK), United Kingdom (UK) (0.08)
    0.03
    0.06
  5. University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK) (0.08)
    0.04
    0.04
  6. Oxford University Hospitals NHS Trust (OUH), United Kingdom (UK) (0.08)
    0.04
    0.04

Top 10 international collaborators by Share (26 total)

  • Southampton Experimental Cancer Medicine Centre (Southampton ECMC), United Kingdom (UK)
  • Foreign institution
  1. HistoGeneX NV, Belgium (0.18)
    0.04
    0.14
  2. F. Hoffmann-La Roche AG, Switzerland (0.16)
    0.04
    0.12
  3. Catalan Health Institute (ICS), Spain (0.10)
    0.04
    0.06
  4. Osaka University, Japan (0.08)
    0.03
    0.06
  5. RIKEN, Japan (0.08)
    0.03
    0.06
  6. Oregon Health and Science University (OHSU), United States of America (USA) (0.08)
    0.03
    0.06
  7. Instituto de Investigación Hospital 12 de Octubre (i+12), Spain (0.08)
    0.04
    0.04
  8. Institute of Biomedicine of Seville (IBiS), Spain (0.08)
    0.04
    0.04
  9. Hospital del Mar, Spain (0.08)
    0.04
    0.04
  10. Hospital Universitario Reina Sofía, Spain (0.08)
    0.04
    0.04

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Southampton Experimental Cancer Medicine Centre (Southampton ECMC)

Participating institutions

Southampton Experimental Cancer Medicine Centre (Southampton ECMC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER